bioMérieux (United States)

Recent papers from bioMérieux (United States)

1. Enabling Ciprofloxacin Resistance-Guided Therapy for Neisseria gonorrhoeae : Aligning Diagnostics, Regulation, Guidelines, and ReimbursementClinical Infectious Diseases · 2026
2. Challenges in establishing epidemiological cut-off values for the Burkholderia cepacia complexJournal of Clinical Microbiology · 2026
3. A comparative analysis of performance and time-to-result for VITEK REVEAL versus MicroScan during antimicrobial susceptibility testing for gram-negative bacteremiaMicrobiology Spectrum · 2026
4. Core genome and whole genome multi-locus sequence typing of Cronobacter isolatesMicrobiology Spectrum · 2026
5. Concerns about “Evaluation of alternative blood culture systems in detecting pathogenic bacteria: a multi-site, observational prospective study” by Hu et al., 2026The Lancet Regional Health - Western Pacific · 2026
6. Machine Learning-Based Prediction of Antimicrobial Resistance in Escherichia coli from MALDI-TOF Mass Spectrometry DataDiagnostics · 2026
7. Clinical Impact of the BIOFIRE® FILMARRAY® Pneumonia Panel in the Veterans Affairs Healthcare System: A Difference-in-Differences StudyClinical Infectious Diseases · 2026
8. A multicenter performance evaluation of aztreonam-avibactam gradient diffusion susceptibility testing for EnterobacteralesJournal of Clinical Microbiology · 2026
9. Planning for the future of the American Society for Microbiology’s Health Unit by the Council on Microbial SciencesmSphere · 2026
10. Antimicrobial Pharmacokinetic and Pharmacodynamic Considerations in Special Populations: A Call to ActionOpen Forum Infectious Diseases · 2026
11. Comparison of Three Methods to Determine the “Safety Margin” Used to Determine Final Release Time of Short-Lived Products per USP <72>PDA Journal of Pharmaceutical Science and Technology · 2026
12. From Bench to Reality: The Role of Natural Contaminations in LER InvestigationsPDA Journal of Pharmaceutical Science and Technology · 2026
13. AI Algorithms in the Pharmaceutical EnvironmentPDA Journal of Pharmaceutical Science and Technology · 2026
14. Comparison of two IGRA assays exploring cell-mediated immunity against CMV, BKV, and EBV in kidney transplant patientsMicrobiology Spectrum · 2026
15. Clinical comparison of the BIOFIRE Joint Infection Panel using synovial fluid and tissue biopsy samplesMicrobiology Spectrum · 2026
16. Cost implications of introducing the BIOFIRE FILMARRAY meningitis/encephalitis panel vs. real-time PCR in adult and pediatric populations in the UKJournal of Medical Economics · 2026
17. Real-world laboratory functionality requirements and implementation considerations for fast phenotypic antimicrobial susceptibility testingDiagnostic Microbiology and Infectious Disease · 2026
18. P-729. Limit of Detection and Inclusivity of a Research-Use-Only (RUO) Prototype of a Multiplexed Sample-to-Answer Diagnostic System for Identification of Sexually Transmitted Infections from Vaginal Swabs and Penile UrineOpen Forum Infectious Diseases · 2026
19. P-716. Limit of Detection and Inclusivity of a Research-Use-Only (RUO) Prototype of a Multiplexed Sample-to-Answer PCR System for the Identification of Vaginal Infections from Vaginal SwabsOpen Forum Infectious Diseases · 2026
20. P-2121. Refining Empiric Therapy: The Influence of Risk Stratification on Antibiotic Prescribing for Diabetic Foot Infections (DFI) Utilizing an Internal GuidelineOpen Forum Infectious Diseases · 2026